Thank You, NCPA 2026! It was great connecting with our customers and industry partners.
YARAL Pharma is bringing a little something different to the 2026 National Community Pharmacists Association (NCPA) Annual Convention & Expo, October 3-6 in Kansas City, Missouri.
YARAL Pharma Brings Build-A-Bear Workshop® Experience to NCPA 2026 Read More »
A guiding philosophy shaping how the company operates, partners, and grows in the U.S. generics market
YARAL Pharma Reinforces Its Commitment to Doing Things Differently Read More »
Compact packaging helps simplify storage, ease inventory concerns, and make daily pharmacy operations more manageable
In this industry-focused, conversational interview, Pharmacy Podcast Network Host Todd Eury speaks with Stephen Beckman, CEO of YARAL Pharma. The discussion explores YARAL Pharma’s commitment to continuity of supply, how consistent on-time delivery supports pharmacy operations, and the company’s philosophy of “Doing Things Differently” — redefining what it means to be a trusted generics partner.
Collaboration expands patient access to the Company’s prescription treatments through online telehealth consultations.
This Collaboration Reflects a Shared Commitment to “Doing Things Differently”.
The YARAL Pharma logo will appear on Hoopes’ race car and uniform throughout the 2025 racing season, starting with his appearance at Maple Grove Raceway in Mohnton, PA on July 19, 2025… Read More
YARAL Pharma Announces Sponsorship of Race Car Driver Charles Hoopes Read More »
FOR IMMEDIATE RELEASE YARAL Pharma and Pharmacy Podcast Network Extend Collaboration Into 2025 Parsippany, N.J. – January 22, 2025 – YARAL Pharma Inc. (YARAL Pharma), the U.S. generics subsidiary of IBSA (Institut Biochimique SA), a multinational pharmaceutical company headquartered in Lugano, Switzerland, today announced that it will continue working with the Pharmacy Podcast Network (PPN),
YARAL Pharma and Pharmacy Podcast Network Extend Collaboration Into 2025 Read More »
YARAL Pharma Reaffirms Commitment to Pharmacists at 2024 NCPA Annual Convention and Expo YARAL Pharma underscored its dedication to supporting pharmacists during this year’s National Community Pharmacists Association (NCPA) Annual Convention and Expo in Columbus, Ohio, which took place from October 26-29. Since its founding, YARAL Pharma has been committed to building strong relationships with
YARAL Pharma Reaffirms Commitment to Pharmacists at 2024 NCPA Annual Convention and Expo Read More »
When it comes to hypothyroidism, not all levothyroxine medications are created equal. Effective July 1, 2024, YARAL Pharma’s Levothyroxine Sodium Capsules — the authorized generic of Tirosint® (levothyroxine sodium) capsules – will be the only generic levothyroxine gel capsule option available in the U.S. market. Formulated to improve the tolerability of LT4 therapy1, these
Optimizing Thyroid Care: The Difference is in the Delivery Read More »
FOR IMMEDIATE RELEASE YARAL PHARMA NOW THE EXCLUSIVE SUPPLIER OF AUTHORIZED GENERIC LEVOTHYROXINE SODIUM CAPSULES IN THE U.S. MARKET Parsippany, NJ – July 9, 2024 – YARAL Pharma Inc. (YARAL Pharma), the U.S. generics subsidiary of IBSA (Institut Biochimique SA), a multinational pharmaceutical company headquartered in Lugano, Switzerland, today announced that they are now the
